Urea derivative, medicinal composition containing the same, and medicinal use of these
申请人:Suzuki Ritsu
公开号:US20080161294A1
公开(公告)日:2008-07-03
Urea derivatives represented by the following general formula (I):
which have an agonism of V2 receptor, are useful as agents for the treatment or prevention of diabetes insipidus, nocturia, nocturnal enuresis, overactive bladder or the like.
In the formula, R
1
represents a hydrogen atom or a C
1-6
alkyl group which may have a substituent, R
2
is a hydrogen atom or a C
1-6
alkyl group, R
3
is a hydrogen atom, a C
1-6
alkyl group or the like, R
4
, R
5
and R
6
are independently a hydrogen atom, a halogen atom or the like, R
7
is a hydrogen atom, a heteroaryl group which may have a substituent, a C
3-8
cycloalkyl group, an amino group which may have a substituent or a C
1-6
alkoxy group which may have a substituted group, M
1
is a single bond, a C
1-4
alkylene group or the like, Y is N or CR
F
(in the formula, and R
F
represents a hydrogen atom, a C
1-6
alkyl group or the like, or pharmaceutically acceptable salts thereof, or prodrugs thereof, or pharmaceutical compositions comprising the same and pharmaceutical uses thereof.
以下通式(I)所表示的尿素衍生物具有V2受体激动剂作用,可用于治疗或预防尿崩症、夜尿症、夜间遗尿、过度活动膀胱等疾病。在该通式中,R1表示氢原子或C1-6烷基,可以有取代基;R2表示氢原子或C1-6烷基;R3表示氢原子、C1-6烷基或类似物;R4、R5和R6独立地表示氢原子、卤素原子或类似物;R7表示氢原子、可以有取代基的杂环芳基、C3-8环烷基、可以有取代基的氨基或可以有取代基的C1-6烷氧基;M1表示单键、C1-4烷基等;Y表示N或CRF(在该式中,RF表示氢原子、C1-6烷基或类似物);以及其药学上可接受的盐、前药或包含它们的制剂,以及其医药用途。